Maria Jaime
Internal Medicine · Homestead, FLNPI 1285874636
Payments from drug & device makers
Across 111 payments — averaging $3772.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- American Regent$191K
- Bausch Health US, LLC$164K
- AbbVie$55K
- Janssen Research & Development, LLC$5K
- Mitsubishi Tanabe Pharma Development America, Inc.$4K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| American Regent | 15 | $191,356 |
| Bausch Health US, LLC | 67 | $163,614 |
| AbbVie | 27 | $55,207 |
| Janssen Research & Development, LLC | 1 | $5,107 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 1 | $3,500 |
How this compares
$418,785 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 186 | $112,927 |
| JanuviaSitagliptin Phosphate | 61 | $74,843 |
| FarxigaDapagliflozin Propanediol | 39 | $36,801 |
| TradjentaLinagliptin | 29 | $30,135 |
| EntrestoSacubitril/Valsartan | 39 | $29,962 |
| OzempicSemaglutide | 27 | $28,948 |
| JardianceEmpagliflozin | 16 | $27,511 |
| ProliaDenosumab | 16 | $27,341 |
| XareltoRivaroxaban | 40 | $21,860 |
| BrilintaTicagrelor | 19 | $12,821 |
| LinzessLinaclotide | 18 | $11,561 |
| TrulicityDulaglutide | 11 | $10,750 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 110 | $9,668 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,370 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $8,322 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Synthroid | $55,207 | $16,07767 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Homestead
- Joel GonzalezHomestead$6.2M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.